
Compounding R.Ph.s demand transparency from FDA over bio-identical hormones
The International Academy of Compounding Pharmacists wants to find out when the Food & Drug Administration became interested in cracking down on the use of estriol for bio-identical hormone replacement therapy.
Still smarting from the Food & Drug Administration's
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.





































































































































